Found: 25
Select item for more details and to access through your institution.
Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer.
- Published in:
- International Journal of Cancer, 1995, v. 63, n. 6, p. 790, doi. 10.1002/ijc.2910630607
- By:
- Publication type:
- Article
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25962-0
- By:
- Publication type:
- Article
Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.
- Published in:
- Journal of Pathology, 1999, v. 189, n. 2, p. 169, doi. 10.1002/(SICI)1096-9896(199910)189:2<169::AID-PATH408>3.0.CO;2-P
- By:
- Publication type:
- Article
Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation.
- Published in:
- Proteomics, 2017, v. 17, n. 5, p. 1, doi. 10.1002/pmic.201600213
- By:
- Publication type:
- Article
Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry.
- Published in:
- Proteomics, 2005, v. 5, n. 10, p. 2680, doi. 10.1002/pmic.200400128
- By:
- Publication type:
- Article
Human VAT-1: a calcium-regulated activation marker of human epithelial cells.
- Published in:
- Archives of Dermatological Research, 2003, v. 295, n. 5, p. 203, doi. 10.1007/s00403-003-0421-8
- By:
- Publication type:
- Article
Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11020-3
- By:
- Publication type:
- Article
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 28, doi. 10.3390/cancers16010028
- By:
- Publication type:
- Article
Loss of Y-Chromosome during Male Breast Carcinogenesis.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 631, doi. 10.3390/cancers12030631
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, p. 1135, doi. 10.1001/jama.2024.3056
- By:
- Publication type:
- Article
Semi-automatic identification of punching areas for tissue microarray building: the tubular breast cancer pilot study.
- Published in:
- BMC Bioinformatics, 2010, v. 11, p. 566, doi. 10.1186/1471-2105-11-566
- By:
- Publication type:
- Article
Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 1, p. 19, doi. 10.1007/s10549-014-3142-0
- By:
- Publication type:
- Article
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 1, p. 47, doi. 10.1007/s10549-013-2415-3
- By:
- Publication type:
- Article
Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 1, p. 125, doi. 10.1007/s10549-009-0545-4
- By:
- Publication type:
- Article
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 110, n. 2, p. 317, doi. 10.1007/s10549-007-9724-3
- By:
- Publication type:
- Article
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
- Published in:
- Breast Cancer Research, 2012, v. 14, n. 5, p. 1, doi. 10.1186/bcr3317
- By:
- Publication type:
- Article
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 8, p. 768, doi. 10.3390/biology10080768
- By:
- Publication type:
- Article
Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 4, p. 1083, doi. 10.1002/ijc.32209
- By:
- Publication type:
- Article
Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 8, p. 1185, doi. 10.3390/cells12081185
- By:
- Publication type:
- Article
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09265-1
- By:
- Publication type:
- Article
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01653-0
- By:
- Publication type:
- Article
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 1, p. 24, doi. 10.1016/j.molonc.2015.07.004
- By:
- Publication type:
- Article
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
- By:
- Publication type:
- Article